NODAL T-FOLLICULAR HELPER CELL LYMPHOMA
Clinical trials for NODAL T-FOLLICULAR HELPER CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new NODAL T-FOLLICULAR HELPER CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for NODAL T-FOLLICULAR HELPER CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a targeted drug boost Chemotherapy's power against a rare lymphoma?
Disease control Not yet recruitingThis trial is testing whether adding the targeted drug golidocitinib to standard chemotherapy can improve outcomes for people with a rare type of lymphoma called nodal T-follicular helper cell lymphoma. The study will include about 47 adults who have not yet received treatment fo…
Matched conditions: NODAL T-FOLLICULAR HELPER CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New chemo cocktail aims to treat rare lymphoma without heart damage
Disease control Not yet recruitingThis phase 2 trial tests a new chemotherapy combination called CAOP for elderly patients (65+) with untreated peripheral T-cell lymphoma, a rare blood cancer. The standard treatment often causes heart damage, but this regimen replaces the heart-toxic drug with a safer one. The st…
Matched conditions: NODAL T-FOLLICULAR HELPER CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC